Desferrioxamine, An Iron Chelator, Induces CXCL8 Expression in U373MG Human Astrocytoma Cells

フォーマット:

論文

責任表示:

Onda, Kaoru ; Yoshida, Hidemi ; Hayakari, Ryo ; Xing, Fei ; Wang, Lian ; Matsumiya, Tomoh ; Kawaguchi, Shogo ; Murakami, Manabu ; Imaizumi, Tadaatsu

言語:

英語

出版情報:

弘前大学大学院医学研究科・弘前医学会, 2016-03-25

著者名:

Onda, Kaoru

Yoshida, Hidemi

Hayakari, Ryo

Xing, Fei

Wang, Lian

Matsumiya, Tomoh

Kawaguchi, Shogo

Murakami, Manabu

Imaizumi, Tadaatsu

続きを見る

掲載情報:

弘前医学

ISSN:

0439-1721      

巻:

66

通号:

2-4

開始ページ:

127

終了ページ:

134

バージョン:

publisher

概要:

Dysregulation of iron homeostasis in brain causes various neurodegenerative disorders. In fact, high concentration of iron is present in brains of patients with Alzheimer’s disease. It was previously reported that CXCL8 protects human neurons from amyloid-β-induced neurotoxicity and that astrocytes have the potential to play important roles in Alzheimer’s disease. In the present study, we examined the effect of desferrioxamine, an iron chelator, on … the expression of CXCL8 in U373MG human astrocytoma cells used as a model of astrocytes. Treatment of the cells with desferrioxamine induced the expression of CXCL8. Pretreatment of the cells with FeSO4 counteracted the positive effect of desferrioxamine on CXCL8 production, suggesting that the effect of desferrioxamine was due to iron chelation. RNA interference experiments showed that HIF-1α was not involved in desferrioxamine-induced CXCL8 expression. We conclude that desferrioxamine induces CXCL8 in astrocytes and the chelation of iron may be a new therapeutic strategy for Alzheimer’s disease. 続きを見る

URL:

http://hdl.handle.net/10129/5808